Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who achieved SVR two or more years ago were less likely to develop hepatocellular carcinoma than those cured more recently.
Stephan Urban, PhD, developed a drug that blocks hepatitis B and D from entering liver cells.
The antiviral treatment is safe and effective for pediatric patients ages 12 and up.
October is Liver Cancer Awareness Month.
Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma.
People with hepatocellular carcinoma had improved survival after the advent of direct-acting antiviral therapy.
However, people with liver cirrhosis remain at risk and should continue screening even after being cured.
Over the past decade, deaths related to HBV rose significantly in West Virginia and Kentucky.
Many people living with hepatitis B and C don’t know it.
Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.
Excess cholesterol can cause liver scarring and inflammation.
The lab is named after the late Steve W. Miller, a widely respected employee of Johnson & Johnson Consumer.
The risk of HCC fell further as cumulative antihistamine use rose in people with HBV, HCV or both.
World Hepatitis Day aims to eliminate viral hepatitis by 2030 by spreading awareness and combating stigma surrounding the disease.
Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.
People with HIV are at greater risk for hepatitis B but are less likely to get vaccinated and respond to vaccines.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.